Mirtazapine and restless leg syndrome: a case report

Therapie. Sep-Oct 2000;55(5):655-6.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists / adverse effects*
  • Adrenergic alpha-Agonists / pharmacokinetics
  • Adrenergic alpha-Agonists / therapeutic use
  • Adult
  • Antidepressive Agents, Tricyclic / adverse effects*
  • Antidepressive Agents, Tricyclic / pharmacokinetics
  • Antidepressive Agents, Tricyclic / therapeutic use
  • Azabicyclo Compounds
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytochrome P-450 Enzyme System / metabolism
  • Depression / drug therapy
  • Drug Therapy, Combination
  • Humans
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / metabolism
  • Male
  • Mianserin / adverse effects*
  • Mianserin / analogs & derivatives*
  • Mianserin / pharmacokinetics
  • Mianserin / therapeutic use
  • Mirtazapine
  • Piperazines / therapeutic use
  • Restless Legs Syndrome / chemically induced*
  • Valproic Acid / analogs & derivatives*
  • Valproic Acid / pharmacokinetics
  • Valproic Acid / therapeutic use

Substances

  • Adrenergic alpha-2 Receptor Agonists
  • Adrenergic alpha-Agonists
  • Antidepressive Agents, Tricyclic
  • Azabicyclo Compounds
  • Cytochrome P-450 Enzyme Inhibitors
  • Isoenzymes
  • Piperazines
  • zopiclone
  • Mianserin
  • Valproic Acid
  • Cytochrome P-450 Enzyme System
  • Mirtazapine
  • dipropylacetamide